SCHEMBL1127170

SCHEMBL1127170

CCc1cc(-c2ccccc2)cn1CCOC

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.43
CNR2 P34972 3/20 0.40
GLO1 Q04760 3/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
HPGD P15428 1/20 0.38
CALCRL Q16602 1/20 0.36
PGR P06401 1/20 0.35
BRD4 O60885 2/20 0.35
NPSR1 Q6W5P4 1/20 0.34
GLA P06280 1/20 0.33
TSHR P16473 1/20 0.33
NFATC1 O95644 1/20 0.33
GSK3B P49841 1/20 0.33
DYRK1A Q13627 1/20 0.33
MAPK1 P28482 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1995016 0.84 ALDH1A1 (0.39) CNR1ALDH1A1LMNAHPGDPGR
SCHEMBL1126837 0.84 BRD4 (0.37) CNR1ALDH1A1LMNAHPGDBRD4
SCHEMBL1988904 0.81 GLA (0.38) CNR1CNR2TDP1GLA
SCHEMBL1126990 0.81 CNR1 (0.45) CNR1CNR2GLO1ALDH1A1LMNA
SCHEMBL1126860 0.78 CNR1 (0.43) CNR1CNR2GLO1ALDH1A1LMNA
SCHEMBL1127347 0.76 CNR1 (0.50) CNR1CNR2GLO1ALDH1A1LMNA
SCHEMBL1127178 0.76 CNR1 (0.44) CNR1CNR2GLO1ALDH1A1LMNA
SCHEMBL1127035 0.76 BRD4 (0.45) CNR1CNR2GLO1ALDH1A1LMNA
SCHEMBL28329745 0.76 CCNC (0.43) LMNAHPGDBRD4RAB9A
SCHEMBL1127393 0.74 BRD4 (0.50) ALDH1A1BRD4GLATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9452168-B2 Pyrrole antifungal agents F2G LTD (GB) 2016-09-27 US disclosed
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-08-27 US disclosed
US-8993574-B2 Pyrrole antifungal agents F2G LTD (GB) 2015-03-31 US disclosed
EP-2283006-B1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2015-02-25 EP disclosed
EP-2626361-B1 Pyrrole antifungal agents F2G LTD (GB) 2014-10-15 EP disclosed
EP-2626361-A1 Pyrrole antifungal agents F2G Limited (GB) 2013-08-14 EP disclosed
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2011-06-23 US disclosed
EP-2283006-A1 PYRROLE ANTIFUNGAL AGENTS F2G Limited (GB) 2011-02-16 EP disclosed
WO-2009130481-A1 PYRROLE ANTIFUNGAL AGENTS F2G LTD (GB) 2009-10-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152285-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 CNR1 1131/4885CNR2 3554/4885GLO1 113/4885
US-20150238500-A1 PYRROLE ANTIFUNGAL AGENTS FOXM1, PYCR1, ARG1 CNR1 1131/4885CNR2 3554/4885GLO1 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.